JOSEPH WYSE: Open Payments
NPI 1669436747 · SKOKIE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,961 in 103 payments from 20 companies in 2025. Trend: 2023 $2,488 · 2024 $2,246 · 2025 $1,961
Food & beverage: $1,961
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $422 |
| PFIZER INC. | 19 | $361 |
| AstraZeneca Pharmaceuticals LP | 14 | $256 |
| ABBVIE INC. | 18 | $244 |
| Amgen Inc. | 10 | $205 |
| Sumitomo Pharma America, Inc. | 2 | $57 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $34 |
Products named: Wegovy, VRAYLAR, PREVNAR 20, ELIQUIS, OTEZLA, FARXIGA, AIRSUPRA, Rybelsus.
Industry payments across IL — which companies pay providers there.
